Techniques in Regional Anesthesia & Pain Management
Volume 13, Issue 4 , Pages 205-211 , October 2009

The mechanism of action and side effects of epidural steroids

  • Aisha Baqai, MD

      Affiliations

    • Department of Anesthesiology, New York Presbyterian Weill Cornell Hospital, New York, New York
    • ,
  • Rajpreet Bal, MD

      Affiliations

    • Department of Pain Management and Anesthesiology, New York Presbyterian Weill Cornell Hospital, New York, New York
    • Corresponding Author InformationAddress reprint requests and correspondence: Rajpreet Bal, MD, Department of Pain Medicine, New York Presbyterian Weill Cornell Hospital, 1305 York Avenue, 10th Floor, New York, NY 10021

References 

  1. Manchikanti L, Singh V. Interventional Techniques in Chronic Spinal Pain (Chapter 23: Lumbar Interlaminar Epidural Steroid Injections). Paducah, KY: ASIPP Publishing; 2007;
  2. Manchikanti L, Singh V. Interventional Techniques in Chronic Spinal Pain (Chapter 11: Pharmacology of Neuraxial Steroids). Paducah, KY: ASIPP Publishing; 2007;
  3. Saal JS. The role of inflammation in lumbar pain. Spine. 1995;20:1821–1827
  4. Imboden J, Goodwin JS, Davis J, et al. Immunosuppressive, anti-inflammatory, and immunomodulatory therapy. In:  Parslow TG,  Stites DP,  Terri AI,  Imboden JB editor. Medical Immunology. ed 10. New York, NY: McGraw Hill; 2001;
  5. Liberman AC, Druker J, Garcia FA, et al. Intracellular molecular signaling. Ann NY Acad Sci. 2009;1153:6–13
  6. Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002;96:23–43
  7. Kuslich SD, Ulstrom CL, Michael CJ. The tissue origin of low back pain and sciatica: A report of pain response to tissue stimulation during operation on the lumbar spine using local anesthesia. Orthop Clin North Am. 1991;22:181–187
  8. Wheeler AH, Murrey DB. Chronic lumbar spine and radicular pain: Pathophysiology and treatment. Curr Pain Headache Rep. 2002;6:97–105
  9. Hoyland JA, Freemont AJ, Jayson MIV. Intervertebral venous obstruction (A cause of periradicular fibrosis). Spine. 1989;14:558–568
  10. McClain RF, Kapural L, Mekhail NA. Epidural steroid therapy for back and leg pain: Mechanisms of action and efficacy. Spine J. 2005;5:191–201
  11. Mulleman D, Mammou S, Griffoul I, et al. Pathophysiology of disk-related sciatica (I. Evidence supporting a chemical component). Joint Bone Spine. 2006;73:151–158
  12. Peng B, Wu W, Li Z, et al. Chemical radiculitis. Pain. 2007;127:11–16
  13. Patte-Mensah C, Kibaly C, Boudard D, et al. Neurogenic pain and steroid synthesis in the spinal cord. J Mol Neurosci. 2006;28:17–31
  14. Mensah-Nyagan AG, Kibaly C, Schaeffer V, et al. Endogenous steroid production in the spinal cord and potential involvement in neuropathic pain modulation. J Steroid Biochem Mol Biol. 2008;109:286–293
  15. Patte-Mensah C, Kibaly C, Mensah-Nyagan AG. Substance P inhibits progesterone conversion into neuroactive metabolites in spinal sensory circuit: A potential component of nociception. Proc Natl Acad Sci U S A. 2005;102:9044–9049
  16. Kibaly C, Meyer L, Patte-Mensah C, et al. Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord. FASEB J. 2008;22:93–104
  17. Johansson A, Hao J, Sjolund B. Local corticosteroid application blocks transmission in normal nociceptive C-fibers. Acta Anaesthesiol Scand. 1990;34:335–338
  18. Van Burskirk C, Poffenbarger AL, Capriles LF, et al. Treatment of multiple sclerosis with intrathecal steroids. Neurology. 1964;14:595–597
  19. Fuxe K, Harfstrand A, Agnati FL. Immunocytochemical studies on the localization of glucocorticoid receptor immunoreactive nerve cells in the lower brain stem and spinal cord of the male rat using a monoclonal antibody against rat liver glucocorticoid receptor. Neurosci Lett. 1985;60:1–6
  20. Finn DP, Fone KCF, Beckett SRG, et al. The effects of pharmacological blockade of the 5-HT6 receptor on Formalin-evoked nociceptive behavior, locomotor activity and hypothalamo-pituitary-adrenal axis activity in rats. Eur J Pharmacol. 2007;569:59–63
  21. Chaouloff F. Regulation of 5-HT receptors by corticosteroids: Where do we stand?. Fundam Clin Pharmacol. 1995;9:219–233
  22. Fukisaki M, Kobayashi I, Hara T, et al. Symptoms of spinal stenosis after epidural steroid injection. Clin J Pain. 1998;14:148–151
  23. Lansang MC, Farmer T, Kennedy L. Diagnosing the unrecognized systemic absorption of intra-articular and epidural steroid injections. Endocr Pract. 2009;15:225–228
  24. Whitworth JA, Williamson PM, Mangos G, et al. Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag. 2005;1:291–299
  25. Tauchamanova L, Rossi R, Biondi B, et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab. 2002;87:4872–4878
  26. Faggiano A, Pivonello R, Spiezia S, et al. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab. 2003;88:2527–2533
  27. Younes M, Neffati F, Touzi M, et al. Systemic effects of epidural and intra-articular glucocorticoid injections in diabetic and non-diabetic patients. Joint Bone Spine. 2007;74:472–476
  28. Ward A, Watson J, Wood P, et al. Glucocorticoid epidural for sciatica: Metabolic and endocrine sequelae. Rheumatology. 2002;41:68–71
  29. Brotman DJ, Girod JP, Garcia MJ, et al. Effects of short-term glucocorticoids on cardiovascular biomarkers. J Clin Endocrinol Metab. 2009;90:3202–3208

PII: S1084-208X(09)00037-8

doi: 10.1053/j.trap.2009.06.009

Techniques in Regional Anesthesia & Pain Management
Volume 13, Issue 4 , Pages 205-211 , October 2009

Article Tools

* Image Usage & Resolution